Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement

0522736 - ÚMG 2020 RIV CH eng J - Článek v odborném periodiku
Formankova, R. - Kanderová, V. - Rackova, M. - Svaton, M. - Brdička, Tomáš - Říha, P. - Keslova, P. - Mejstříková, E. - Žaliová, M. - Freiberger, T. - Grombirikova, H. - Zemanová, Z. - Vlková, M. - Fencl, F. - Copova, I. - Bronsky, J. - Jabandžiev, P. - Sedláček, P. - Šoukalová, J. - Zapletal, O. - Starý, J. - Trka, J. - Kalina, T. - Kramarzova, K.S. - Hlavackova, E. - Litzman, J. - Froňková, E.
Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement.
Frontiers in Immunology. Roč. 10, September (2019), č. článku 2194. ISSN 1664-3224. E-ISSN 1664-3224
Institucionální podpora: RVO:68378050
Klíčová slova: samd9 * mirage * immunodeficiency * neutropenia * cytomegalovirus infection * dysphagia * hematopoietic stem cell transplantation * gastrointestinal disorder
Obor OECD: Immunology
Impakt faktor: 5.085, rok: 2019
Způsob publikování: Open access
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02194/full

Mutations in the Sterile alpha motif domain containing 9 (SAMD9) gene have been described in patients with severe multisystem disorder, MIRAGE syndrome, but also in patients with bone marrow (BM) failure in the absence of other systemic symptoms. The role of hematopoietic stem cell transplantation (HSCT) in the management of the disease is still unclear. Here, we present a patient with a novel mutation in SAMD9 (c.2471 G >A, p.R824Q), manifesting with prominent gastrointestinal tract involvement and immunodeficiency, but without any sign of adrenal insufficiency typical for MIRAGE syndrome. He suffered from severe CMV (cytomegalovirus) infection at 3 months of age, with a delayed development of T lymphocyte functional response against CMV, profound T cell activation, significantly reduced B lymphocyte counts and impaired lymphocyte proliferative response. Cultured T cells displayed slightly lower calcium flux and decreased survival. At the age of 6 months, he developed severe neutropenia requiring G-CSF administration, and despite only mild morphological and immunophenotypical disturbances in the BM, 78% of the BM cells showed monosomy 7 at the age of 18 months. Surprisingly, T cell proliferation after CD3 stimulation and apoptosis of the cells normalized during the follow-up, possibly reflecting the gradual development of monosomy 7. Among other prominent symptoms, he had difficulty swallowing, requiring percutaneous endoscopic gastrostomy (PEG), frequent gastrointestinal infections, and perianal erosions. He suffered from repeated infections and periodic recurring fevers with the elevation of inflammatory markers. At 26 months Frontiers of age, he underwent HSCT that significantly improved hematological and immunological laboratory parameters. Nevertheless, he continued to suffer from other conditions, and subsequently, he died at day 440 post-transplant due to sepsis. Pathogenicity of this novel SAMD9 mutation was confirmed experimentally. Expression of mutant SAMD9 caused a significant decrease in proliferation and increase in cell death of the transfected cells.
Trvalý link: http://hdl.handle.net/11104/0307182